Menopause
Conference Coverage
Zoledronate reduces fracture risk in elderly women with osteopenia
Women with osteopenia who received intravenous zoledronate had a significantly lower risk of fractures.
Conference Coverage
Migraine and menopause: Longitudinal study shows what to expect
From the Journals
High testosterone in postmenopausal women may add CVD risk
Having more testosterone than estrogen may spell heart disease after menopause.
Video
VIDEO: Stem cells may reverse premature menopause, restore fertility
CHICAGO – In addition to bringing estrogen levels closer to normal, the treatment diminishes other menopause symptoms.
From the Journals
Menopause accelerates RA functional decline
Findings were based on surveys of over 8,000 women.
From the Journals
Don’t choose hormones to protect postmenopausal women
The USPSTF has issued a recommendation against using estrogen or estrogen plus progestin to prevent chronic conditions in postmenopausal women.
Opinion
Strategies to evaluate postmenopausal bleeding
Pros and cons of blind and targeted sampling.
From the Journals
Papillary thyroid microcarcinoma: Is ‘less is more’ the right approach?
Expert questions whether current guidance favoring total thyroidectomy goes too far.
Conference Coverage
VIDEO: Expert roundtable on hormone therapy
Some of the experts who crafted the 2017 NAMS position statement on hormone therapy discuss the new messages for clinicians and the evidence to...
Conference Coverage
VIDEO: Dr. Andrew Kaunitz’s top lessons from NAMS 2017
PHILADELPHIA – Dr. Kaunitz shares what he learned about migraines, breast imaging, and the connection between type 2 diabetes and the risk for...
Conference Coverage
VIDEO: Does genitourinary syndrome of menopause capture all the symptoms?
PHILADELPHIA - Preliminary research shows GSM doesn’t always match up with women’s symptoms.